perindopril has been researched along with Body Weight in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (9.30) | 18.7374 |
| 1990's | 21 (48.84) | 18.2507 |
| 2000's | 13 (30.23) | 29.6817 |
| 2010's | 4 (9.30) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barzel, B; Burke, SL; Cooper, ME; Eikelis, N; Gueguen, C; Head, GA; Jackson, KL; Jandeleit-Dahm, KAM; Jha, JC; Lambert, GW; Lim, K; Sata, Y; Thomas, MC; Watson, AMD | 1 |
| Mathai, ML; Naik, S; Sinclair, AJ; Weisinger, HS; Weisinger, RS | 1 |
| Amann, K; Boor, P; Heidland, A; Lill, M; Sebeková, K | 1 |
| Cole, TJ; Morris, MJ; Smith, I; Velkoska, E; Warner, FJ | 1 |
| Batty, GD; Chalmers, J; Czernichow, S; Grobbee, DE; Huxley, R; Kengne, AP; Neal, B; Ninomiya, T; Woodward, M | 1 |
| Campbell, DJ; Gilbert, RE; Kelly, DJ; McCarthy, DJ; Shi, W; Smyth, GK; Zhang, Y | 1 |
| Avolio, AP; Hildreth, CM; Ng, K; Phillips, JK | 1 |
| Delbridge, LM; Morgan, TO; Trongtorsak, P | 1 |
| Andrikopoulos, S; Candido, R; Cooper, ME; Thomas, MC; Tikellis, C; Wookey, PJ | 1 |
| Erensoy, N; Hatemi, H; Oztürk, M; Tunçdemir, M; Uysal, O; Yilmazer, S | 1 |
| Gao, YJ; He, CC; Lee, RM; Li, N; Luo, BH; Su, CJ; Yi, JJ; Zeng, ZH | 1 |
| Begg, DP; Chen, N; Jayasooriya, AP; Mathai, ML; Sinclair, AJ; Wark, JD; Weisinger, HS; Weisinger, RS; Wilkinson-Berka, J | 1 |
| Begg, DP; Egan, GF; Jayasooriya, AP; Lie, F; Mathai, ML; Sinclair, AJ; Wark, JD; Weisinger, HS; Weisinger, RS | 1 |
| Chemla, D; Desché, P; Lecarpentier, Y; Lerebours, G; Scalbert, E; Suard, I | 1 |
| Corman, B; Kreher, P; Ristori, MT; Verdetti, J | 1 |
| Cooper, ME; Doyle, AE; Rumble, JR | 1 |
| Bertram, JF; Black, MJ; Bobik, A; O'Sullivan, JB | 1 |
| Datodi, SR; Harrap, SB; Lever, AF; Mirakian, C | 1 |
| Head, GA; Minami, N | 1 |
| Cooper, ME; Doyle, AE; Jerums, G; O'Brien, RC | 1 |
| Higaki, J; Higashimori, K; Mikami, H; Morishita, R; Nagano, M; Nakamura, F; Ogihara, T | 1 |
| Hardy, KJ; Shulkes, A; Tancheroen, S | 1 |
| Funder, JW; Young, MJ | 1 |
| Burrell, LM; Campbell, DJ; Duncan, AM; Kladis, A | 1 |
| Christensen, S; Hansen, AK; Marcussen, N; Shalmi, M | 1 |
| Black, MJ; Bobik, A; Kanellakis, P | 1 |
| Delaney, KH; Kwiecien, JM; Lee, RM; Smeda, JS; Wang, H | 1 |
| Anderson, WP; Bergström, G; Johansson, I; Kett, MM; Stevenson, KM | 1 |
| Gu, XH; Kompa, AR; Summers, RJ | 1 |
| Anastasopoulos, F; Briscoe, TA; Campbell, DJ; Duncan, AM; James, GM; Kladis, A | 1 |
| Arnolda, LF; Bune, AJ; Chalmers, JP; Gabb, GM; Harvey, PJ; Molloy, D; Upton, J; Wing, LM | 1 |
| Lantelme, P; Lo, M; Sassard, J | 1 |
| Matsuda, K; Noguchi, K; Ozaki, M; Sekiguchi, F; Shibano, T; Shimamura, K; Sunano, S; Tanaka, M; Yamamoto, K | 1 |
| Bertram, JF; Black, MJ; Johnston, CI | 1 |
| Delbridge, LM; Griffiths, CD; Morgan, TO | 1 |
| Cooper, ME; Kelly, DJ; Mifsud, SA; Skinner, SL; Wilkinson-Berka, JL | 1 |
| Atkinson, J; Capdeville-Atkinson, C; Chillon, JM; Henrion, D; Vinceneux-Feugier, M | 1 |
| Abdon, D; Fauchère, JL; Narcisse, G; Santoni, JP; Scalbert, E | 1 |
| Atkinson, J; Bray, L; Burlet, C; Capdeville, C; Janian, P; Lartaud, I; Muller, F | 1 |
| Charlon, V; Kreher, P; Rossi, A; Thollon, C | 1 |
| Hodsman, GP; Howes, LG; Johnston, CI; Rowe, PR; Sumithran, E | 1 |
| Auzan, C; Choudat, L; Corvol, P; Dussaule, JC; Menard, J; Michel, JB; Nochy, D | 1 |
| Cadilhac, M; Giudicelli, JF | 1 |
2 trial(s) available for perindopril and Body Weight
| Article | Year |
|---|---|
Impact of blood pressure lowering on cardiovascular outcomes in normal weight, overweight, and obese individuals: the Perindopril Protection Against Recurrent Stroke Study trial.
Topics: Aged; Antihypertensive Agents; Body Weight; Cardiovascular Diseases; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Obesity; Overweight; Perindopril; Placebos; Proportional Hazards Models; Recurrence; Risk Reduction Behavior; Stroke | 2010 |
Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Body Weight; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Drug Resistance; Heart Rate; Humans; Hypertension; Indapamide; Indoles; Middle Aged; Perindopril | 1998 |
41 other study(ies) available for perindopril and Body Weight
| Article | Year |
|---|---|
Empagliflozin modulates renal sympathetic and heart rate baroreflexes in a rabbit model of diabetes.
Topics: Animals; Baroreflex; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Glucosides; Heart Rate; Male; Perindopril; Rabbits; Sodium-Glucose Transporter 2 Inhibitors; Sympathetic Nervous System | 2020 |
Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats.
Topics: Absorptiometry, Photon; Adipose Tissue; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Composition; Body Weight; Bone Density; Eating; Leptin; Male; Perindopril; Rats; Rats, Sprague-Dawley | 2008 |
Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Diabetic Nephropathies; Kidney Function Tests; Kidney Glomerulus; Male; Organ Size; Oxidative Stress; Perindopril; Proteinuria; Random Allocation; Rats; Rats, Zucker; Tetrazoles | 2009 |
Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
Topics: Adipose Tissue; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Diet; Dietary Fats; Energy Intake; Energy Metabolism; Insulin; Leptin; Lipid Metabolism; Liver; Male; Obesity; Organ Size; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Sprague-Dawley; Time Factors | 2010 |
Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart.
Topics: Aldosterone; Amides; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Female; Fumarates; Heart; Kallikreins; Kidney; Lung; Mice; Myocytes, Cardiac; Perindopril; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tissue Kallikreins | 2011 |
Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease.
Topics: Aging; Anatomy, Cross-Sectional; Angiotensin-Converting Enzyme Inhibitors; Animals; Arteries; Blood Pressure; Body Weight; Calcinosis; Calcium; Collagen; Compliance; Elasticity; Female; Hypertension, Renal; Kidney Diseases, Cystic; Male; Perindopril; Rats; Vascular Stiffness | 2011 |
Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Dose-Response Relationship, Drug; Heart; Losartan; Male; Myocardial Contraction; Myocytes, Cardiac; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium, Dietary | 2003 |
Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cell Division; Fasting; Glucose Tolerance Test; Irbesartan; Islets of Langerhans; Male; Perindopril; Rats; Rats, Zucker; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Tetrazoles | 2004 |
Effects of ACE inhibition on the expression of type IV collagen and laminin in renal glomeruli in experimental diabetes.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Basement Membrane; Blood Glucose; Body Weight; Collagen Type IV; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique, Indirect; Kidney Glomerulus; Kidney Tubules; Laminin; Male; Perindopril; Rats; Rats, Wistar | 2004 |
Control of vascular changes by renin-angiotensin-aldosterone system in salt-sensitive hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Blood Vessels; Body Weight; Capsaicin; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Perindopril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sodium, Dietary; Spironolactone; Telmisartan | 2004 |
Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats.
Topics: Adipose Tissue; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Eating; Fatty Acids, Omega-3; Hypertension; Male; Perindopril; Rats; Renin | 2008 |
Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats.
Topics: Absorptiometry, Photon; Adipose Tissue; Animals; Animals, Newborn; Behavior, Animal; Blood Pressure; Body Composition; Body Weight; Enzyme Inhibitors; Feeding Behavior; Female; Heart Rate; Magnetic Resonance Imaging; Male; Peptidyl-Dipeptidase A; Perindopril; Rats; Rats, Sprague-Dawley | 2008 |
Effects of early and late therapy with perindopril on survival and myocardial inotropic state in experimental dilated cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomyopathy, Dilated; Cricetinae; Disease Models, Animal; Indoles; Male; Mesocricetus; Myocardial Contraction; Peptidyl-Dipeptidase A; Perindopril; Survival Analysis | 1994 |
Effects of chronic angiotensin I-converting enzyme inhibition on the relations between ventricular action potential changes and myocardial hypertrophy in aging rats.
Topics: Action Potentials; Aging; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Cell Division; Disease Models, Animal; Electrophysiology; Germ-Free Life; Heart Ventricles; In Vitro Techniques; Indoles; Male; Organ Size; Perindopril; Random Allocation; Rats; Renin-Angiotensin System | 1995 |
Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Hypertension; Indoles; Kidney Diseases; Male; Perindopril; Random Allocation; Rats; Rats, Inbred SHR; Renin | 1995 |
Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Hypertension, Renovascular; Hypertrophy; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred WKY; Tetrazoles | 1994 |
Blood pressure and lifespan following brief ACE inhibitor treatment in young spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Indoles; Life Expectancy; Male; Perindopril; Rats; Rats, Inbred SHR | 1994 |
Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
Topics: Animals; Blood Pressure; Blood Vessels; Body Weight; Cardiomegaly; Cerebrovascular Disorders; Drinking; Heart Rate; Hypertension; Hypertrophy; Indoles; Male; Perindopril; Pressoreceptors; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reflex | 1993 |
The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Glomerular Filtration Rate; Glomerular Mesangium; Hydralazine; Hydrochlorothiazide; Indoles; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Sprague-Dawley; Reserpine | 1993 |
The angiotensin-converting enzyme inhibitor, perindopril, prevents cardiac hypertrophy in low-renin hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Heart Rate; Hypertension, Renal; Hypertrophy, Left Ventricular; Indoles; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Radioimmunoassay; Rats; Rats, Wistar; Renin; Sodium Chloride | 1993 |
Premedication with cyclosporine and perindopril modifies the ischaemia-reperfusion injury during liver resection in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bilirubin; Body Weight; Cyclosporine; Hepatectomy; Immunosuppressive Agents; Indoles; Liver; Liver Function Tests; Male; Organ Size; Perindopril; Premedication; Prothrombin Time; Rats; Rats, Wistar; Reperfusion Injury | 1996 |
The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.
Topics: Aldosterone; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Canrenoic Acid; Cardiomegaly; Collagen; Corticosterone; Epithelium; Fibrosis; Heart; Imidazoles; Indoles; Losartan; Male; Myocardium; Nephrectomy; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renin-Angiotensin System; Tetrazoles | 1996 |
Effects of angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptides in rats with myocardial infarction.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Bradykinin; Heart; Indoles; Male; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley | 1996 |
Effects of perindopril and hydrochlorothiazide on the long-term progression of lithium-induced chronic renal failure in rats.
Topics: Animals; Animals, Newborn; Antihypertensive Agents; Blood Pressure; Body Weight; Creatinine; Disease Models, Animal; Drug Interactions; Female; Glomerular Filtration Rate; Hydrochlorothiazide; Indoles; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Tubules, Proximal; Lithium; Male; Perindopril; Pregnancy; Rats; Sodium; Spectrophotometry, Atomic; Urea; Uremia | 1997 |
Role of angiotensin II in early cardiovascular growth and vascular amplifier development in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Antihypertensive Agents; Body Weight; Cardiomegaly; Cardiovascular System; Hypertension; Hypertrophy; Indoles; Kidney; Losartan; Male; Mesenteric Arteries; Organ Size; Papaverine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Vascular Resistance | 1997 |
Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Brain; Cerebral Cortex; Cerebrovascular Disorders; Heart Rate; Hypertension; Indoles; Kidney; Kidney Diseases; Male; Perindopril; Prospective Studies; Rats; Rats, Inbred SHR; Survival Rate; Time Factors | 1997 |
Perindopril treatment affects both preglomerular renal vascular lumen dimensions and in vivo responsiveness to vasoconstrictors in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Glomerular Filtration Rate; Hemodynamics; Hypertension; Indoles; Kidney; Male; Organ Size; Perindopril; Rats; Rats, Inbred SHR; Renal Artery; Vasoconstrictor Agents | 1998 |
Regulation of beta-adrenoceptors in a rat model of cardiac failure: effect of perindopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Autoradiography; Blood Pressure; Body Weight; Down-Regulation; Female; Heart Failure; Indoles; Iodocyanopindolol; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Pindolol; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta | 1998 |
Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Bradykinin; Cardiomegaly; Cyclic GMP; Drug Synergism; Indoles; Male; Myocardial Infarction; Neprilysin; Peptidyl-Dipeptidase A; Perindopril; Potassium; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Renin; Sodium; Thiorphan | 1999 |
Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diastole; Dose-Response Relationship, Drug; Heart Rate; Hypertension; Kidney Cortex; Male; Norepinephrine; Perindopril; Rats; Renin; Renin-Angiotensin System; Sodium; Systole; Time Factors | 2000 |
Effect of chronic treatment with perindopril on endothelium-dependent relaxation of aorta and carotid artery in SHRSP.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Body Weight; Carotid Arteries; Dose-Response Relationship, Drug; Endothelium, Vascular; Male; Nitroprusside; Norepinephrine; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2000 |
Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Capillaries; Coronary Circulation; Dose-Response Relationship, Drug; Heart; Hypertension; Hypertrophy, Left Ventricular; Perindopril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reference Values; Systole; Ventricular Function, Left | 2001 |
Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Behavior, Animal; Blood; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Drug Synergism; Eating; Heart; Losartan; Organ Size; Perindopril; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2001 |
Effects of low-dose and early versus late perindopril treatment on the progression of severe diabetic nephropathy in (mREN-2)27 rats.
Topics: Animals; Animals, Genetically Modified; Blood Pressure; Body Weight; Collagen; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glomerulosclerosis, Focal Segmental; Kidney; Kidney Medulla; Organ Size; Perindopril; Rats; Renin; Systole | 2002 |
Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, protects in vitro carbachol-induced vasorelaxation in a rat model of vascular calcium overload.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Body Weight; Calcium; Carbachol; Cholecalciferol; Endothelium, Vascular; Heart Rate; In Vitro Techniques; Indoles; Magnesium; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nicotine; Nitroprusside; Norepinephrine; Perindopril; Rats; Rats, Inbred Strains; Splanchnic Circulation | 1991 |
Systemic and regional hemodynamic interactions of perindopril and nitrendipine in the spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diuresis; Drug Synergism; Heart Rate; Indoles; Male; Nitrendipine; Perindopril; Rats; Rats, Inbred SHR; Tissue Distribution | 1990 |
Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, restores the lower limit of autoregulation of cerebral blood flow in the awake renovascular hypertensive rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cerebrovascular Circulation; Heart Rate; Homeostasis; Hypertension; Hypertrophy; Indoles; Kidney; Male; Myocardium; Organ Size; Perindopril; Rats; Rats, Inbred Strains | 1990 |
Hypertrophy induced alteration of action potential and effects of the inhibition of angiotensin converting enzyme by perindopril in infarcted rat hearts.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Disease Models, Animal; Female; Indoles; Myocardial Infarction; Perfusion; Perindopril; Rats; Rats, Inbred Strains; Renin-Angiotensin System | 1989 |
Cardiac 3,4-dihydroxyphenylethylene glycol (DHPG) and catecholamine levels during perindopril therapy of chronic left ventricular failure in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Catecholamines; Chronic Disease; Female; Glycols; Indoles; Methoxyhydroxyphenylglycol; Myocardial Infarction; Myocardium; Organ Size; Perindopril; Rats; Rats, Inbred Strains | 1989 |
Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Clonidine; Dihydralazine; Drug Therapy, Combination; Furosemide; Hydralazine; Hypertension, Renovascular; Indoles; Kidney; Male; Organ Size; Perindopril; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; Time Factors | 1986 |
Myocardial and vascular effects of perindopril, a new converting enzyme inhibitor, during hypertension development in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arteries; Body Weight; DNA; Heart; Hemodynamics; Indoles; Perindopril; Rats; Rats, Inbred SHR | 1986 |